UPDATE : Tuesday, November 12, 2019
상단여백
Lilly reports improved survival for Verzenio in P3 trial
Eli Lilly Korea said that Verzenio (Ingredient: Abemaciclib) demonstrated a...
by Lee Han-soo  |  2019-08-07 12:06
라인
ISU Abxis to unveil p1 results for anticancer treatment in Europe
ISU Abxis will present its phase 1 clinical trial data for ISU104, an Erb-B...
by Lee Han-soo  |  2019-08-07 12:03
라인
Crystal Genomics signs accord with CRO firm
Crystal Genomics said that it has signed an agreement with PRA Health Scien...
by Lee Han-soo  |  2019-08-06 17:20
라인
Japanese firms fear boycott may hurt prescription drug sales
Korean offshoots of Japanese pharmaceutical companies are worrying that the...
by Kim Yun-mi  |  2019-08-06 15:44
라인
Sillajen cites salvation therapy as reason for trial suspension advice
Sillajen said that it believes that the Independent Data Monitoring Committ...
by Lee Han-soo  |  2019-08-06 15:43
라인
Market value of biopharmaceuticals drops ₩10 trillion on 'Black Monday'
Biopharmaceutical shares in the nation’s secondary bourse had their worst d...
by Lee Han-soo  |  2019-08-06 13:50
라인
Crystal Genomics confirms efficacy of inflammatory bowel disease treatment
Crystal Genomics said that it has confirmed the efficacy of CG-598, an infl...
by Lee Han-soo  |  2019-08-05 17:02
라인
Boycott of Japanese drug intensifies as Seoul-Tokyo relations worsen
With Japan deciding to remove South Korea from the list of trusted trading ...
by Lee Han-soo  |  2019-08-05 16:01
라인
Amgen’s lipid-lowering Repatha beats Sanofi’s Praluent in Q2 sales
Amgen won the battle against Sanofi in sales of cholesterol-lowering PCSK9 ...
by Kim Yun-mi  |  2019-08-05 15:37
라인
Helixmith unveils results for neuromuscular disease treatment
Helixmith has published a study that confirmed the efficacy of AV6-H’s, a g...
by Lee Han-soo  |  2019-08-02 17:52
라인
‘MSD Korea playing tricks to maintain monitoring on salespersons’
MSD Korea’s labor and management are again in dispute over the so-called “s...
by Kim Yun-mi  |  2019-08-02 15:48
라인
Conflict erupts between employees of Takeda, Shire during merger
Takeda Pharmaceutical Korea’s labor union said Takeda employees faced unfai...
by Kim Yun-mi  |  2019-08-02 14:23
라인
Sillajen likely to scrap global P3 trials for Pexa-Vec
Sillajen is in danger of aborting its phase 3 clinical trial for Pexa-Vec (...
by Lee Han-soo  |  2019-08-02 10:29
라인
KAIST-Hanyang University team presents new anticancer principle
Researchers at Korea Advanced Institute of Science & Technology (KAIST) and...
by Lee Han-soo  |  2019-08-01 17:30
라인
Health ministry to reimburse Novartis’ Revolade treating severe aplastic anemia
Novartis Korea’s Revolade (ingredient: eltrombopag) will receive reimbursem...
by Lee Han-soo  |  2019-08-01 13:36
라인
New weight loss drug Qsymia wins local approval
The local drug regulator has approved a new obesity treatment, Qsymia Cap. ...
by Lee Hye-seon  |  2019-08-01 10:57
라인
‘Hanmi’s Carnitil improves cognitive function in patients’
Hanmi Pharmaceutical said that it has presented the phase 4 clinical trial ...
by Lee Han-soo  |  2019-07-31 17:05
라인
Hanall marks record sales in Q2
Hanall Biopharma said that it registered record-breaking sales and operatin...
by Lee Han-soo  |  2019-07-31 17:00
라인
Novartis fails to expand heart failure drug Entresto’s indication
Novartis said its phase-3 Paragon-HF trial on heart failure treatment Entre...
by Kim Yun-mi  |  2019-07-31 14:26
라인
Hanmi marks ₩270.4 billion in Q2 sales
Hanmi Pharmaceutical said Tuesday that it recorded sales of 270.4 billion w...
by Lee Han-soo  |  2019-07-30 17:26
여백
여백
여백
Back to Top